NCT02522104View on ClinicalTrials.gov

Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH)

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 3, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 28, 2016

Conditions
Sickle Cell DiseaseRenal Function Disorder
Interventions
DRUG

Siklos

Trial Locations (1)

Unknown

Centre de Référence des Syndromes Drépanocytaires Majeurs, Hôpital Henri-Mondor, Créteil

Sponsors

Lead Sponsor

Theravia
All Listed Sponsors
lead

Theravia

INDUSTRY

NCT02522104 - Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH) | Biotech Hunter | Biotech Hunter